Locations:
Search
APOL1 gene variants are associated with increased risk
A possible association between ACE2 and TMPRSS2 polymorphisms and COVID-19 susceptibility
New research elucidates key role of WISP1 protein
$2 million will enable preclinical dose and efficacy testing of “compound 3”
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Largest-to-date evaluation of germline mutations in this population demonstrates the value of genetics evaluation and genetic testing
Bruce Trapp, PhD, reflects on decades of basic and translational research
$2M NIH grant will help see if dual-action agent lengthens treatment window
Meet the Director of Cleveland Clinic’s new Center for Immunotherapy and Precision Immuno-Oncology
Defect in myosin binding may explain why a significant percentage of patients do not adequately respond to anti-TNF therapy
Tools to aid in diagnosis, complication management and lifestyle interventions
Advertisement
Advertisement